These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 34063568)

  • 1. Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer.
    Ryu J; Thomas SN
    Molecules; 2021 May; 26(9):. PubMed ID: 34063568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
    Hüttenhain R; Choi M; Martin de la Fuente L; Oehl K; Chang CY; Zimmermann AK; Malander S; Olsson H; Surinova S; Clough T; Heinzelmann-Schwarz V; Wild PJ; Dinulescu DM; Niméus E; Vitek O; Aebersold R
    Mol Cell Proteomics; 2019 Sep; 18(9):1836-1850. PubMed ID: 31289117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel proteomic technologies to address gaps in pre-clinical ovarian cancer biomarker discovery efforts.
    Jordan HA; Thomas SN
    Expert Rev Proteomics; 2023; 20(12):439-450. PubMed ID: 38116719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of ovarian cancer: functional insights and clinical applications.
    Elzek MA; Rodland KD
    Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis.
    Zhang W; Peng P; Ou X; Shen K; Wu X
    BMC Cancer; 2019 Nov; 19(1):1095. PubMed ID: 31718609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.
    Pitteri SJ; JeBailey L; Faça VM; Thorpe JD; Silva MA; Ireton RC; Horton MB; Wang H; Pruitt LC; Zhang Q; Cheng KH; Urban N; Hanash SM; Dinulescu DM
    PLoS One; 2009 Nov; 4(11):e7916. PubMed ID: 19936259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic profiling in ovarian cancer.
    Kim G; Minig L; Kohn EC
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2(Suppl 2):S2-6. PubMed ID: 19955909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis for early detection of ovarian cancer: a realistic approach?
    Stevens EV; Liotta LA; Kohn EC
    Int J Gynecol Cancer; 2003; 13 Suppl 2():133-9. PubMed ID: 14656269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MASS SPECTROMETRY-BASED MITOCHONDRIAL PROTEOMICS IN HUMAN OVARIAN CANCERS.
    Li N; Zhan X
    Mass Spectrom Rev; 2020 Sep; 39(5-6):471-498. PubMed ID: 32020673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer: can proteomics give new insights for therapy and diagnosis?
    Toss A; De Matteis E; Rossi E; Casa LD; Iannone A; Federico M; Cortesi L
    Int J Mol Sci; 2013 Apr; 14(4):8271-90. PubMed ID: 23591842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry-based proteomics techniques and their application in ovarian cancer research.
    Swiatly A; Plewa S; Matysiak J; Kokot ZJ
    J Ovarian Res; 2018 Oct; 11(1):88. PubMed ID: 30270814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular diagnostics of ovarian cancer using proteome techniques].
    Vlasova MA; Moshkovskiĭ SA; Safarova MP; Makarov OV; Archakov AI
    Biomed Khim; 2005; 51(4):367-83. PubMed ID: 16223028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.
    Wei BR; Hoover SB; Ross MM; Zhou W; Meani F; Edwards JB; Spehalski EI; Risinger JI; Alvord WG; Quiñones OA; Belluco C; Martella L; Campagnutta E; Ravaggi A; Dai RM; Goldsmith PK; Woolard KD; Pecorelli S; Liotta LA; Petricoin EF; Simpson RM
    PLoS One; 2009 Oct; 4(10):e7670. PubMed ID: 19888321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
    Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
    PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.
    Huang R; Chen Z; He L; He N; Xi Z; Li Z; Deng Y; Zeng X
    Theranostics; 2017; 7(14):3559-3572. PubMed ID: 28912895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
    Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
    Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
    Nossov V; Amneus M; Su F; Lang J; Janco JM; Reddy ST; Farias-Eisner R
    Am J Obstet Gynecol; 2008 Sep; 199(3):215-23. PubMed ID: 18468571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics as a guiding tool for more effective personalized therapy.
    Lee JM; Kohn EC
    Ann Oncol; 2010 Oct; 21 Suppl 7(Suppl 7):vii205-10. PubMed ID: 20943616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.